Back to Search
Start Over
Vaccine development for chronic myelogenous leukaemia.
- Source :
-
Lancet . 2/19/2005, Vol. 365 Issue 9460, p631-632. 2p. 1 Color Photograph. - Publication Year :
- 2005
-
Abstract
- Focuses on efforts to develop a vaccine for chronic myelogenous leukemia (CML). Claim that CML has been responsive to immunotherapy and hematopoietic stem-cell transplantation; Outcome of a clinical trial of a BRC-ABL peptide vaccine for CML; Issues impacting the success of CML vaccines; Impact of using imatinib as a treatment for CML.
Details
- Language :
- English
- ISSN :
- 01406736
- Volume :
- 365
- Issue :
- 9460
- Database :
- Academic Search Index
- Journal :
- Lancet
- Publication Type :
- Academic Journal
- Accession number :
- 16179361
- Full Text :
- https://doi.org/10.1016/S0140-6736(05)17957-4